Live News EQUITY FLASH M impact Nov 17, 2026, 09:45 PM UTC Biogen’s Diranersen Slowed Clinical Decline by 38% at Two Years The reported result used the CDR-SB measure and a 60 mg twice-yearly regimen. BIIB SquawkNews Desk